South Korea
6
2012-01-12
6
2012-12-25
These are the the leading inventors for applications assigned to ViroMed Co., Ltd.:
ViroMed Co., Ltd. based in , KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
#2 | 2011-07-07 ✅ Patent 8,389,492 granted on 2013-03-05Lyophilized DNA formulations for enhanced expression of plasmid DNA
#3 | 2010-11-11 ✅ Patent 8,106,158 granted on 2012-01-31Compositions and methods for fusion protein separation
#4 | 2010-08-19 ✅ Patent 8,445,268 granted on 2013-05-21Her-2/neu DNA vaccine having anti-cancer activity
#5 | 2009-05-21 ✅ Patent 7,838,505 granted on 2010-11-23Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
#6 | 2006-05-23 ✅ Patent 7,049,143 granted on 2006-05-23High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor
433708 ⎘